100 related articles for article (PubMed ID: 1354726)
1. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats.
Morimoto K; Iwakura Y; Nakatani E; Miyazaki M; Tojima H
J Pharm Pharmacol; 1992 Mar; 44(3):216-8. PubMed ID: 1354726
[TBL] [Abstract][Full Text] [Related]
2. Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.
Morimoto K; Yamaguchi H; Iwakura Y; Miyazaki M; Nakatani E; Iwamoto T; Ohashi Y; Nakai Y
Pharm Res; 1991 Sep; 8(9):1175-9. PubMed ID: 1724082
[TBL] [Abstract][Full Text] [Related]
3. Human calcitonin delivery in rats by iontophoresis.
Thysman S; Hanchard C; Préat V
J Pharm Pharmacol; 1994 Sep; 46(9):725-30. PubMed ID: 7837041
[TBL] [Abstract][Full Text] [Related]
4. Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats.
Tozaki H; Odoriba T; Iseki T; Taniguchi T; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1998 Aug; 50(8):913-20. PubMed ID: 9751457
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration.
Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P
Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596
[TBL] [Abstract][Full Text] [Related]
6. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.
Santi P; Colombo P; Bettini R; Catellani PL; Minutello A; Volpato NM
Pharm Res; 1997 Jan; 14(1):63-6. PubMed ID: 9034222
[TBL] [Abstract][Full Text] [Related]
7. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.
Nakamura K; Katagai K; Mori K; Higo N; Sato S; Yamamoto K
Int J Pharm; 2001 May; 218(1-2):93-102. PubMed ID: 11337153
[TBL] [Abstract][Full Text] [Related]
8. Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers.
Kobayashi S; Kondo S; Juni K
Pharm Res; 1994 Sep; 11(9):1239-43. PubMed ID: 7816750
[TBL] [Abstract][Full Text] [Related]
9. Transdermal iontophoretic delivery of salmon calcitonin.
Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
Int J Pharm; 2000 Apr; 200(1):107-13. PubMed ID: 10845691
[TBL] [Abstract][Full Text] [Related]
10. In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin.
Chaturvedula A; Joshi DP; Anderson C; Morris RL; Sembrowich WL; Banga AK
Int J Pharm; 2005 Jun; 297(1-2):190-6. PubMed ID: 15907605
[TBL] [Abstract][Full Text] [Related]
11. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones.
Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
J Control Release; 2000 May; 66(2-3):127-33. PubMed ID: 10742574
[TBL] [Abstract][Full Text] [Related]
12. Passive and iontophoretic controlled delivery of salmon calcitonin through artificial membranes.
Stamatialis DF; Rolevink HH; Koops GH
Curr Drug Deliv; 2004 Apr; 1(2):137-43. PubMed ID: 16305379
[TBL] [Abstract][Full Text] [Related]
13. In vivo iontophoretic delivery of salmon calcitonin across microporated skin.
Vemulapalli V; Bai Y; Kalluri H; Herwadkar A; Kim H; Davis SP; Friden PM; Banga AK
J Pharm Sci; 2012 Aug; 101(8):2861-9. PubMed ID: 22644951
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.
Morita T; Yamamoto A; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
Oh DH; Chun KH; Jeon SO; Kang JW; Lee S
Eur J Pharm Biopharm; 2011 Oct; 79(2):357-63. PubMed ID: 21683790
[TBL] [Abstract][Full Text] [Related]
16. [Study on pulmonary delivery system of salmon calcitonin in rats].
Wang Z; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):329-32. PubMed ID: 12914259
[TBL] [Abstract][Full Text] [Related]
17. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide.
Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
Drug Dev Ind Pharm; 2013 Apr; 39(4):520-5. PubMed ID: 22564052
[TBL] [Abstract][Full Text] [Related]
18. Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation.
Dogru ST; Calis S; Oner F
J Clin Pharm Ther; 2000 Dec; 25(6):435-43. PubMed ID: 11123497
[TBL] [Abstract][Full Text] [Related]
19. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.
Banga AK; Chien YW
Pharm Res; 1993 May; 10(5):697-702. PubMed ID: 8321834
[TBL] [Abstract][Full Text] [Related]
20. Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect.
Mansoor S; Youn YS; Lee KC
Pharm Dev Technol; 2005; 10(3):389-96. PubMed ID: 16176019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
